These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 10977467

  • 1. Proton pump inhibitor therapy: preliminary results of a therapeutic interchange program.
    Amidon PB, Jankovich R, Stoukides CA, Kaul AF.
    Am J Manag Care; 2000 May; 6(5):593-601. PubMed ID: 10977467
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of patients with Zollinger-Ellison syndrome.
    Mignon M, Pospai D, Forestier S, Vatier J, Vallot T.
    Clin Ther; 1993 May; 15 Suppl B():22-31. PubMed ID: 8205592
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL, Huang B, Amer F, Christopoulos NG.
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Lansoprazole-associated microscopic colitis: a case series.
    Thomson RD, Lestina LS, Bensen SP, Toor A, Maheshwari Y, Ratcliffe NR.
    Am J Gastroenterol; 2002 Nov; 97(11):2908-13. PubMed ID: 12425567
    [Abstract] [Full Text] [Related]

  • 11. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
    Avidan B, Melzer E, Keller N, Bar-Meir S.
    Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
    [Abstract] [Full Text] [Related]

  • 12. Proton pump inhibitor formulary considerations in the acutely ill. Part 2: Clinical efficacy, safety, and economics.
    Devlin JW, Welage LS, Olsen KM.
    Ann Pharmacother; 2005 Nov; 39(11):1844-51. PubMed ID: 16204393
    [Abstract] [Full Text] [Related]

  • 13. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
    Ohara T, Morishita T, Suzuki H, Masaoka T, Ishii H.
    Hepatogastroenterology; 2004 Nov; 51(56):338-42. PubMed ID: 15086153
    [Abstract] [Full Text] [Related]

  • 14. Second-line treatment for Helicobacter pylori infection in Japan: proton pump inhibitor-based amoxicillin and metronidazole regimen.
    Nagahara A, Miwa H, Kawabe M, Kurosawa A, Asaoka D, Hojo M, Iijima K, Terai T, Ohkusa T, Miyazaki A, Sato N.
    J Gastroenterol; 2004 Nov; 39(11):1051-5. PubMed ID: 15580397
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Factors influencing the shift of patients from one proton pump inhibitor to another: the effect of direct-to-consumer advertising.
    Hansen RA, Shaheen NJ, Schommer JC.
    Clin Ther; 2005 Sep; 27(9):1478-87. PubMed ID: 16291421
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
    Güliter S, Keleş H, Ozkurt ZN, Cengiz DU, Kolukisa E.
    Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
    [Abstract] [Full Text] [Related]

  • 20. Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine.
    Miyake K, Ueki N, Suzuki K, Shinji Y, Kusunoki M, Hiratsuka T, Nishigaki H, Tatsuguchi A, Futagami S, Wada K, Tsukui T, Nakajima A, Yoshino S, Sakamoto C.
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():67-72. PubMed ID: 15943850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.